Opaleye Management Inc. bought $30k of GRCE
owner at Acasti Pharma Inc.. 14,632 shares at an average of $2.03, traded Oct 8, 2026, filed Oct 13, 2026.
Score components
This filing reached EDGAR on Oct 13, 2026, so its score and components open to free visitors on Oct 20, 2026. The trade itself, the rows in the filing and the price context are public now.
What happened after comparable buys
Same side and tier, against the S&P 500, at 1, 3 and 6 months. Shown to Pro users; the whole table is on the backtest page.
Price around the trade, and since
From a quarter before the trade to today. The arrow is the trade, the circle the day the filing reached EDGAR, which is the first day anyone outside could act; the dotted line is the S&P 500 rebased to that day's close.
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value; the dashed line is the close on the filing day, the dotted line SPY rebased to it.Charts by TradingView Lightweight Charts™
Rows in this filing
Every transaction in Form 4 0001493152-26-046899, as filed. Open on EDGAR
| Date | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|
| Oct 8, 2026 | POpen-market purchase Common Stock, par value $0.0001 per shareindirect: By Opaleye, L.P. | +2,077 | $2.02 | $4,190 | 2,860,734 | 3 h ago |
| Oct 9, 2026 | POpen-market purchase Common Stock, par value $0.0001 per shareindirect: By Opaleye, L.P. | +5,340 | $2.04 | $11k | 2,866,074 | 3 h ago |
| Oct 12, 2026 | POpen-market purchase Common Stock, par value $0.0001 per shareindirect: By Opaleye, L.P. | +7,215 | $2.02 | $15k | 2,873,289 | 3 h ago |
Related signals
Other insiders at Acasti Pharma Inc. and this insider’s other filings.
| Score | Company | Insider | Value | Holdings | Filed |
|---|---|---|---|---|---|
| 45Moderate | GRCEbuy Acasti Pharma Inc. | Opaleye Management Inc. owner | $124k 60,490 shares | +2% | |
| 30Weak | GRCEbuy Acasti Pharma Inc. | Opaleye Management Inc. owner | $16k 7,849 shares | +0% | |
| 38Weak | Acasti Pharma Inc. | Opaleye Management Inc. owner | $32k 15,089 shares | +1% | |
| 38Weak | Acasti Pharma Inc. | Opaleye Management Inc. owner | $32k 15,089 shares | +1% | |
| 73Notable | Acasti Pharma Inc. | Prashant Kohli Chief Executive Officer | $214k 100,000 shares | +468% | |
| 33Weak | Acasti Pharma Inc. | Opaleye Management Inc. owner | $32k 15,229 shares | +1% | |
| 25Weak | GRCEbuy Acasti Pharma Inc. | Opaleye Management Inc. owner | $24k 11,608 shares | +0% |
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.